"A not-for-profit, 199-licensed bed, Joint Commission accredited, acute care hospital serving a wide geographical area in South-Central Kansas."

During the past decade, Hutchinson Regional Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 35 clinical trials were completed, i.e. on average, 3500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 11 clinical trials were completed. i.e. 1100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hutchinson Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "C. R. Bard" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hutchinson Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hutchinson Regional Medical Center" are "Recurrent Melanoma" (4 trials), "Prostate Cancer" (3 trials), "Adenocarcinoma of the Gastroesophageal Junction" (2 trials), "Adult B Acute Lymphoblastic Leukemia" (2 trials) and "Adult T Acute Lymphoblastic Leukemia" (2 trials). Many other conditions were trialed in "Hutchinson Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Hutchinson Regional Medical Center" are "Drug" (36 trials), "Other" (23 trials), "Biological" (20 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Bevacizumab" (8 trials), "Cyclophosphamide" (5 trials), "Cisplatin" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hutchinson Regional Medical Center" are 35 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hutchinson Regional Medical Center". undefined are not yet recruiting, 1 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Hutchinson Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hutchinson Regional Medical Center, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".